1 – 10 of 20
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
The hidden story of heterogeneous B-raf V600E mutation quantitative protein expression in metastatic melanoma—association with clinical outcome and tumor phenotypes
(
- Contribution to journal › Article
- 2003
-
Mark
Differential prognostic impact of the cyclins E and B in premenopausal and postmenopausal women with lymph node-negative breast cancer
(
- Contribution to journal › Article
-
Mark
Expression of cyclins E, A, and B, and prognosis in lymph node-negative breast cancer
(
- Contribution to journal › Article
- 2002
-
Mark
DNA ploidy in soft tissue sarcoma: Comparison of flow and image cytometry with clinical follow-up in 93 patients : comparison of flow and image cytometry with clinical follow-up in 93 patients
(
- Contribution to journal › Article
-
Mark
Cytogenetic aberrations and their prognostic impact in chondrosarcoma
(
- Contribution to journal › Article
- 2001
-
Mark
Optimizing flow cytometric DNA ploidy and S-phase fraction as independent prognostic markers for node-negative breast cancer specimens
(
- Contribution to journal › Article
-
Mark
Concurrent overexpression of p53 and c-erbB-2 correlates with accelerated cycling and concomitant poor prognosis in node-negative breast cancer
(
- Contribution to journal › Article
- 1999
-
Mark
Immunologic proliferation marker Ki-S2 as prognostic indicator for lymph node-negative breast cancer
(
- Contribution to journal › Article
-
Mark
Correlation between p53, c-erbB-2, and topoisomerase II alpha expression, DNA ploidy, hormonal receptor status and proliferation in 356 node-negative breast carcinomas : prognostic implications
(
- Contribution to journal › Article
-
Mark
Prognostic implications of various models for calculation of S-phase fraction in 259 patients with soft tissue sarcoma
(
- Contribution to journal › Article